CURRENTLY HELD GRANTS:

2015-2017 - Cancer Research Society (CRS)- Investigating the role of surgery-induced Myeloid Derived Supressor Cells in postoperative immune suppression and cancer recurrence.

2015-2018 - Canadian Cancer Society Research Institute (CCSRI) - Innate immune evasion by the cancers of the blood and breast.

2015-2026 - Lotte and John Hecht - The Thoracic Peri-Operative Integrative Surgical Care Evaluation (POISE) Trial

2015-2019 - Canadian Cancer Society Research Institute (CCSRI) - Combining oncolytic vaccines (OVax) with surgery and immune modulation to prevent postoperative cancer recurrence and metastases.

2015-2020 - Networks of Centers of Excellence - Biotherapeutics for Cancer Treatment (BioCanRx)

2014-2019 - New Investigator Salary Award - Canadian Institute of Health Research (CIHR) - A Translational Approach to Targeting the Perioperative Period with Innovative Cancer Therapies.

2012-2016 - Early Research Award - Ministry of Research and Innovation (MRI) - A Translational Approach to Targeting Natural Killer Cells in the Perioperative Period with Innovative Cancer Therapies.